Overview

Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section

Status:
Completed
Trial end date:
2019-01-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative pain free experience, and more stable hemodynamic.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Menoufia University
Treatments:
Bupivacaine
Dexmedetomidine